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218a Monday, March 7, 2011resistance is associated with inadequate target inhibition. Here we report our
most recent efforts to create the analytical and chemical tools needed to directly
measure the enzymatic activities of therapeutic targets including protein ki-
nases, lipid-modifying enzymes and the proteasome. Fluorescent reagents are
under development that report the activity of these various enzymes with the
goal of performing biochemical assays in primary cells. The basic design incor-
porates enzyme substrates that are modified to create compounds which can be
loaded into cells where they are modified by the enzyme of interest. Work has
included modification of peptides to confer membrane permeability and to
achieve long intracellular lifetimes. Microelectrophoretic separations com-
bined with low-level fluorescence detection enable the quantitative analysis
of these compounds from single mammalian cells. This capability addresses
three major issues currently faced in the biochemical analysis of clinical sam-
ples: the need for direct measurement of the enzymatic activity of target pro-
teins; sample size requirements that are feasible for clinical implementation;
and sample heterogeneity that can mask pertinent aspects related to therapeutic
response.
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CDP-Chase, a CDP-Choline Pyrophosphatase, is a Member of a Novel
Nudix Family in Gram-Positive Bacteria
Krisna C. Duong-Ly, Sandra B. Gabelli, WenLian Xu, Christopher A. Dunn,
Maurice J. Bessman, L. Mario Amzel.
A Nudix enzyme from Bacillus cereus, CDP-Chase, acts as a CDP-choline
pyrophosphatase, hydrolyzing the phosphoanhydride bond of CDP-choline
to produce CMP and phosphocholine. The structure of the free enzyme, de-
termined to 1.8 A˚ resolution, shows that the enzyme is an asymmetric dimer.
Each monomer consists of two domains, an N-terminal helical domain and
a C-terminal Nudix domain. The N-terminal domain is placed relative to
the C-terminal domain in such a way that produces an overall asymmetry.
Residues that may be important for determining the asymmetry are conserved
among a group of uncharacterized Nudix enzymes from Gram-positive bac-
teria. In addition to its Nudix activity, the enzyme has a 3’ to 5’ RNA exo-
nuclease activity. This alternative activity appears to be facilitated by the
asymmetry in the protein as the position of the N-terminal domain results
in differences in the exposure of the two enzyme active sites. Two single-
site mutations, E112A and E163A, were characterized to further investigate
the mechanism of the enzyme. E112 is involved in the coordination of cata-
lytic metals in both active sites, and E163 is only in close proximity in one of
the active sites. Both mutations abolish CDP-choline pyrophosphatase activ-
ity but E112A has a much more profound effect on RNase activity, support-
ing a model where CDP-choline hydrolysis is catalyzed by one active site of
the dimer and RNA exonuclease activity is catalyzed by the other. These data
suggest that CDP-Chase is a member of a novel Nudix family in which struc-
tural asymmetry has a profound effect on the recognition of substrates by the
Nudix enzymatic machinery.
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Active Sites of Enzymes are Crowded with Charge
David Jimenez-Morales, Jie Liang, Bob Eisenberg.
The chemistry of enzymes occurs at active sites that concentrate biological
function into functional pockets. Functional pockets mix catalytic amino acids
and substrate in tiny volumes. Here, we look for biological properties of that
small space. We imagine that electric charge plays important roles, because
even one charge in a small space produces large electric fields. To estimate den-
sities of fixed charge, we measure the volume of functional pockets and count
‘charged residues’ in it. We collect locations of functional pockets from en-
zymes of known structure that catalyze the main six enzymatic reactions. Func-
tional amino acids are identified by their participation in catalysis. We measure
the volume of pockets using both solvent-accessible and molecular-surface
models. ‘Charged residues’ are R, K and H (positive); E and D (negative).
Charge density is extraordinarily large (~20 Molar on average, often larger).
Mobile counterions for the fixed charge are presumably nearby in high density.
Active sites do not resemble the infinitely dilute ideal solutions of classical en-
zyme kinetics. Their enormous charge density is comparable to the charge den-
sity of solid NaCl. Different types of enzymes have different charge densities.
Hydrolases show the largest values of charge density. Some enzymes have ex-
traordinarily large charge density -phosphoglycerate mutase (PDB = 1o98, den-
sity of charge 104 Molar, Molecular Surface), or sulfurtransferase (PDB =
1e0c, 109 Molar, Molecular Surface). Crowding of charged side-chains and
ions produces enormous steric and electrostatic forces in these tiny active sites.
The balance of these forces seems likely to be of great importance to enzyme
function. Many charged pockets are also found away from active sites. Charged
pockets are likely to be involved in many surface interactions. They may be res-
ervoirs of electromechanical energy that can drive conformational changes.1192-Pos Board B102
Strong Coulomb Interactions Between Internal and Surface Charges in
Proteins
Victor Khangulov, Carlos A. Castaneda, Michael S. Chimenti, Michael
J. Harms, Daniel G. Isom, Jamie L. Schlessman, Bertrand E. Garcia-Moreno.
Internal ionizable groups in proteins are essential for many biological pro-
cesses. The molecular determinants of their pKa values are poorly understood.
To examine this problem, we measured previously the pKa values of Lys, Arg,
Asp and Glu at 25 internal positions in staphylococcal nuclease. The pKa values
are usually shifted substantially (as many as 6 pKa units) in the direction that
favors the neutral state because dehydration experienced by the ionizable
groups in their buried positions is not compensated by interactions with polar
or charged groups. A subset of variants with internal Lys residues showed ev-
idence of interaction of the internal Lys with surface carboxylic groups. Using
NMR spectroscopy and crystallography we have shown that internal Lys resi-
dues can have significant Coulomb interactions with surface Asp and Glu.
Upon ionization the internal Lys residue remains internal and the proteins re-
main fully folded. The interactions between the internal Lys and surface car-
boxylic groups are long range (6.3 A˚ or more between charged atoms) and
are mostly through protein. Long-range pairwise interactions as high as 2
kcal/mol have been measured. In some cases strong effects are governed by
the sum of many weaker long-range interactions that cannot be decomposed ex-
perimentally into pairwise contributions. Overall, there is strong evidence that
surface carboxylic groups stabilize the charged form of many internal Lys res-
idues. The experimentally measured Coulomb interaction energies between in-
ternal and surface charges constitute invaluable constraints for benchmarking
of structure-based electrostatics calculations. They also suggest a strategy for
modifying the pKa value of active site residues by the engineering of surface
charges.
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Enzyme-Triggered Anticancer Lipid Prodrugs
Ahmad Arouri, Palle J. Pedersen, Sidsel K. Adolph, Mogens W. Madsen,
Thomas L. Andresen, Robert Madsen, Mads H. Clausen, Ole G. Mouritsen.
The use of liposomal drug delivery systems for cancer treatment is primarily
hampered by the complications associated with making liposomal encapsula-
tions that are: 1) stable outside the target area and 2) provide efficient drug re-
lease at the target. The escape of encapsulated drugs from the liposomes by
passive diffusion often leads to suboptimal drug concentrations in the cancer
tissues. Hence, we have constructed lipid prodrugs that can form liposomes
and therefore overcome the necessity for liposome drug loading. The prodrugs
were prepared using ether phospholipids esterified in the sn-2 position to anti-
cancer drugs like chlorambucil, retinoic acids or prostaglandin, where the ac-
tive drug can be released at the target tissue by means of secretory
phospholipase A2 (sPLA2), an enzyme that is upregulated in various cancer tis-
sues. In this work, the biophysical characterization, cytotoxicity and enzymatic
hydrolysis of the prodrugs are presented. It is also shown how the mixing of the
prodrugs with sPLA2-cleavable phospholipids was found to enhance the prop-
erties of the liposomal formulation and to strengthen its targeting capacity.
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Inhibitors of Leishmania Major Farnesyl Diphosphate Synthase: Crystal-
lographic and Calorimetric Studies
Srinivas Aripirala, Sandra Gabelli, Eric Oldfield, Dolores
Gonzalez Pacanowska, Mario Amzel.
Leishmaniasis is a parasitic disease predominantly seen in tropical and subtropi-
cal regions. Different Leishmania species are responsible for different forms of
the disease: Viscereal Leishmaniasis, Cutaneous Leishmaniasis and Mucutane-
ous Leishmaniasis. Cutaneous Leishmaniasis, which is caused, by either L. Trop-
icaorL.major affects around1.5millionpeople everyyear. It is transmittedby the
bite of the sandfly, an intermediate host. Rodriguez et. al showed that the bi-
sphosphonates, such as pamidronate inhibit the growth of lesions in mice when
administered intraperitoneally. BPs target the Farnesyl Diphosphate synthase
(FPPS), an enzyme of themevalonate pathway in both parasite and humans, . Ki-
netic studies on LmFPPS showed that the Km for DMAPP is 53 mM. Inhibition
cell based studies against intracellular L. donovani amastigotes show that the
IC50 values for 1-(2-Hydroxy-2,2-bis-phosphono-ethyl) 3-phenyl-pyridinium
